Pepcid Complete

Colic, Heartburn, Flatulence + 6 more
Treatment
6 FDA approvals
20 Active Studies for Pepcid Complete

What is Pepcid Complete

Magnesium hydroxideThe Generic name of this drug
Treatment SummaryCalcium carbonate is a salt that helps to neutralize stomach acid. Taking it can reduce the amount of acid in the stomach, which may help protect the stomach lining and reduce irritation. It is often used as an antacid to relieve heartburn, stomach ache, or indigestion. Calcium carbonate can also be taken as a dietary supplement or to treat low calcium levels.
Milk of Magnesiais the brand name
image of different drug pills on a surface
Pepcid Complete Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Milk of Magnesia
Magnesium hydroxide
1977
109

Approved as Treatment by the FDA

Magnesium hydroxide, also known as Milk of Magnesia, is approved by the FDA for 6 uses such as Constipation and Heartburn .
Constipation
Helps manage Constipation
Heartburn
Heartburn
Constipation
Helps manage Constipation
Upset stomach
Indigestion

Effectiveness

How Pepcid Complete Affects PatientsGastric-peptic disease is caused by an imbalance of things that can protect your stomach, like mucus and bicarbonate, and things that can cause harm, like acid and the bacteria Helicobacter pylori. Antacids help to restore balance by reducing acid and pepsin activity and increasing bicarbonate and prostaglandin production. Calcium carbonate is a type of antacid that neutralizes 58 mEq of acid per 15 ml. When taken as a supplement, it increases the amount of calcium stored in the body.
How Pepcid Complete works in the bodyCalcium carbonate is a type of salt that helps neutralize stomach acid and block the effects of pepsin. It does this by raising the pH levels and preventing pepsin from working as it should. Calcium carbonate also helps protect cells by increasing bicarbonate and prostaglandins. When taken, it breaks down into calcium chloride, carbon dioxide and water. Most of the calcium chloride then turns into insoluble calcium salts like calcium carbonate and calcium phosphate.

When to interrupt dosage

The advised measure of Pepcid Complete is contingent upon the recognized disorder, including Gastric Ulcer, Dyspepsia and Acid indigestion. The dosage varies as indicated by the technique of delivery (e.g. Tablet or Oral) outlined in the table beneath.
Condition
Dosage
Administration
Upset stomach
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Stomach Ulcer
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Constipation
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Indigestion
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Colic
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Heartburn
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Flatulence
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Antacid therapy
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream
Gastroesophageal Reflux
200.0 mg/mL, , 400.0 mg/mL, 165.0 mg, 120.0 mg/mL, 240.0 mg/mL, 400.0 mg, 311.0 mg, 80.0 mg/mL, 200.0 mg, 300.0 mg, 110.0 mg/mL, 235.0 mg, 110.0 mg, 135.0 mg/mL, 105.0 mg, 7.75 %, 0.25 %, 120.0 mg, 385.0 mg, 64.0 mg, 70.0 mg, 350.0 mg, 27.0 mg/mL, 0.02 mg/mg, 0.2 mg/mg, 142.0 mg/mL, 40.0 mg, 0.04 mg/mg, 270.0 mg, 135.0 mg, 40.0 mg/mL, 125.0 mg, 50.0 mg, 1200.0 mg, 700.0 mg, 100.0 mg, 55.0 mg, 60.0 mg, 25.0 mg/mL, 31.5 mg/mL, 500.0 mg/mL, 343.0 mg, 0.135 mg/mg, 150.0 mg, 90.0 mg, 90.0 mg/mL, 350.0 mg/mL, 100.0 mg/mL, 300.0 mg/mL, 250.0 mg/mL, 145.0 mg/mL, 60.0 mg/mL, 0.4 mg/mg, 0.64 %/mL, 440.0 mg/mL, 26.0 mg, 56.0 mg
Oral, Liquid, Liquid - Oral, , Suspension - Oral, Tablet, chewable, Suspension, Tablet, chewable - Oral, Ointment, Topical, Tablet, Ointment - Topical, Tablet - Oral, Emulsion, Emulsion - Oral, Gel - Oral, Concentrate - Oral, Concentrate, Solution - Oral, Solution, Capsule, Tablet, coated - Oral, Kit - Oral, Kit, Cream - Oral, Tablet, coated, Lozenge, Lozenge - Oral, Gel, Capsule - Oral, Cream

Warnings

There are 20 known major drug interactions with Pepcid Complete.
Common Pepcid Complete Drug Interactions
Drug Name
Risk Level
Description
2,5-Dimethoxy-4-ethylamphetamine
Major
The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be increased when it is combined with Magnesium hydroxide.
2,5-Dimethoxy-4-ethylthioamphetamine
Major
The serum concentration of 2,5-Dimethoxy-4-ethylthioamphetamine can be increased when it is combined with Magnesium hydroxide.
4-Bromo-2,5-dimethoxyamphetamine
Major
The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be increased when it is combined with Magnesium hydroxide.
Amphetamine/Dextroamphetamine
Major
The serum concentration of Amphetamine can be increased when it is combined with Magnesium hydroxide.
Atazanavir
Major
Magnesium hydroxide can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
image of a doctor in a lab doing drug, clinical research

Pepcid Complete Novel Uses: Which Conditions Have a Clinical Trial Featuring Pepcid Complete?

Currently, 75 active clinical trials are examining the effects of Pepcid Complete in relieving Hypovitaminosis D, Fracture and Calcium and Vitamin D Deficiencies.
Condition
Clinical Trials
Trial Phases
Gastroesophageal Reflux
0 Actively Recruiting
Heartburn
2 Actively Recruiting
Phase 3, Not Applicable
Flatulence
0 Actively Recruiting
Upset stomach
0 Actively Recruiting
Colic
0 Actively Recruiting
Antacid therapy
0 Actively Recruiting
Constipation
18 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1
Indigestion
6 Actively Recruiting
Phase 3, Not Applicable, Phase 2
Stomach Ulcer
2 Actively Recruiting
Phase 4, Not Applicable

Pepcid Complete Reviews: What are patients saying about Pepcid Complete?

5Patient Review
1/25/2011
Pepcid Complete for Heartburn
Protonic didn't work well for me, but my doctor recommended Pepcid Complete Dual Action and it was a total game changer. I haven't been able to find it at any pharmacies recently though. Do you have any information on this?
5Patient Review
11/28/2010
Pepcid Complete for Indigestion
PC is great, but I can't find it anywhere anymore.
5Patient Review
12/3/2015
Pepcid Complete for Heartburn
I've been taking this over-the-counter chewable medicine for at least 10 years. It is my "miracle drug". Two seconds after chewing it my heartburn goes away, and stays away for 12 hours.
5Patient Review
1/3/2011
Pepcid Complete for Heartburn
I've always had great results with Pepsid Complete AC-0ral tablets for my indigestion, but I can't seem to find them anywhere these days. If anyone knows where I could get my hands on some, that would be greatly appreciated!
5Patient Review
10/17/2010
Pepcid Complete for Treatment to Prevent Heartburn
This is a great preventative measure for heartburn.
5Patient Review
10/6/2012
Pepcid Complete for Condition in which Stomach Acid is Pushed Into the Esophagus
I have some reservations about this medication because it can be difficult to obtain, and last year it was pulled from store shelves without any explanation given to consumers. That said, it's the only thing that has been effective in eliminating my pain, so I continue to take it despite my concerns.
5Patient Review
2/22/2014
Pepcid Complete for Indigestion
This treatment provided me with much needed relief.
5Patient Review
9/16/2013
Pepcid Complete for Prevent Indigestion
This medication really helps to prevent colon pain from I.B.S. when taken before Excedrine for migraines.
5Patient Review
11/19/2011
Pepcid Complete for Heartburn
I no longer have to suffer from heartburn at night. I can finally sleep peacefully.
5Patient Review
3/28/2009
Pepcid Complete for Condition in which Stomach Acid is Pushed Into the Esophagus
Pepcid Complete has been a game changer for me. I was using Aciphex, but this medication works so much better and lasts all day long.
5Patient Review
12/29/2010
Pepcid Complete for Heartburn
Pepcid is, by far, the best heartburn medication I've tried. It works quickly and lasts a long time. Plus, the pills taste great!
5Patient Review
1/18/2011
Pepcid Complete for Heartburn
This medication does a great job at treating acid reflux. Please don't discontinue it!
4.7Patient Review
6/15/2013
Pepcid Complete for Indigestion
I started taking Gabapentin for back pain, but soon developed debilitating headaches at night. After some research, I realized that the Pepcid I was also taking was likely exacerbating this problem. Sure enough, once I stopped taking Pepcid, my headaches went away.
4.3Patient Review
2/1/2010
Pepcid Complete for Condition in which Stomach Acid is Pushed Into the Esophagus
I just tried this for the first time when I was feeling bloated and painful after eating. It worked very quickly to bring me relief. I'm quite pleased!
4Patient Review
11/8/2010
Pepcid Complete for Heartburn
I've been using this ointment for a little while now and it seems to be helping my rash. I also had some swelling in my ankles, but that has since gone down. I stopped taking the Pepcid and will see if that was the cause of the problem.
3Patient Review
4/11/2011
Pepcid Complete for Heartburn
This medication can cause your stool to appear dark in color. If this is a concern for you, please speak with your doctor.
2.3Patient Review
3/18/2020
Pepcid Complete for Heartburn
I had no idea this medication would be loaded with aspartame, an artificial sweetener which causes me a range of negative physical responses like heartburn, headaches, dizziness, increased blood pressure, insomnia and anxiety.
2.3Patient Review
12/24/2013
Pepcid Complete for Condition in which Stomach Acid is Pushed Into the Esophagus
My doctor recommended Pepcid Complete as a way to alleviate my acid reflux faster than the other medication he prescribed. Unfortunately, I woke up in the middle of the night with horrible chest pains due to esophageal spasm and this did nothing to help. In fact, over the course of 10 hours, I took 3 tablets with no relief whatsoever.
2.3Patient Review
5/19/2022
Pepcid Complete for Indigestion
I didn't find this medication effective at treating heartburn.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about pepcid complete

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is so special about Pepcid Complete?

"There are two types of PEPCID AC, original and maximum strength, which both contain an H2 blocker that begins to work within 15-30 minutes. PEPCID Complete combines an H2 blocker with an antacid that starts neutralizing acid in your stomach almost immediately."

Answered by AI

Is it OK to take Pepcid Complete everyday?

"To avoid heartburn, take a tablet 15-60 minutes before eating or drinking anything that gives you heartburn. Do not take more than 2 tablets in 24 hours unless your doctor tells you to. Do not take this medicine for more than 14 days in a row without talking to your doctor."

Answered by AI

What are side effects of taking Pepcid Complete?

"You may experience diarrhea, headache, constipation, or stomach cramps. If you experience any of these effects for an extended period of time, or if they worsen, contact your doctor or pharmacist. Your doctor has determined that the benefits of this medication outweigh the risks of side effects."

Answered by AI

What is the difference between PEPCID and Pepcid Complete?

"PEPCID is a medication that reduces stomach acid. Original Strength and Maximum Strength PEPCID AC start working in 15-30 minutes, and help control stomach acid all day or all night. Dual Action PEPCID COMPLETE combines an H2 blocker with an antacid, so it starts neutralizing acid in seconds, but has the long-lasting relief of an H2 blocker."

Answered by AI

Clinical Trials for Pepcid Complete

Image of Center for Nutraceutical and Dietary Supplement Research in Memphis, United States.

Inno Cleanse for Abdominal Bloating

18+
All Sexes
Memphis, TN
The purpose of the present study is to investigate the impact of a natural dietary supplement, Inno Cleanse™, to reduce bloating in a population of otherwise healthy men and women, who claim to feel frequently bloated. Inno CleanseTM dietary supplement is manufactured in the United States under current Good Manufacturing Practices (cGMP) and is marketed by InnoSupps as a digestive health aid. It is sold in the United States on the company's website, Amazon, and in many large retail outlets. It remains a very popular product, with close to 1.4 million units sold since 2020, with a reported 66,000 units sold in the past three months. Despite the prevalence of dietary supplements identifying as digestive aids, detoxification, and cleanses, very little research has been done to determine their effectiveness. The product appears to be well-designed, with multiple ingredients included which have scientific evidence of effectiveness. That said, and despite the overall positive reviews, there is no known clinical research to support the product's effectiveness. Therefore, the aim of this study is to evaluate the efficacy of the Inno Cleanse product to reduce bloating and result in other positive outcomes (weight loss). This study will be run as a double-blind placebo-controlled trial, in which subjects will use the product or placebo for two weeks. It is hypothesized that treatment with the dietary supplement Inno Cleanse will result in reduced bloating, as evidenced by self-reported reductions in bloating and hunger, as well as moderate weight loss and a reduction in body circumference measures due to the reduced bloating. In addition, multiple anecdotal reports of improved skin health have been noted in those using the product. Additionally, routine blood and urine sample analysis will be performed as a secondary outcome, as a safety measure.
Recruiting
Paid Trial
Center for Nutraceutical and Dietary Supplement ResearchRichard Bloomer, PhD
Image of Banner - University Medical Center South in Tucson, United States.

Dexmedetomidine + Dexamethasone for Postoperative Pain

18 - 75
All Sexes
Tucson, AZ
The goal of this clinical study is to improve upon the standard practice of utilizing nerve blocks to enhance the satisfaction of patients undergoing shoulder, or foot and ankle surgery regarding their quality of pain control, the duration of their nerve blocks, as well as the avoidance of opioid medications and subsequently their undesirable side effects. The researchers hypothesize that dexmedetomidine and dexamethasone (Dex-Dex) will work synergistically as adjuncts in a low, non-weight based formula. This would allow the investigators to improve patient satisfaction by providing them with a superior means of pain control that is longer in duration with a decreased probability of unwanted side effects. The proposed clinical study will be a prospective, randomized control trial.
Phase 1 & 2
Waitlist Available
Banner - University Medical Center SouthRonald Tang, MD
Have you considered Pepcid Complete clinical trials? We made a collection of clinical trials featuring Pepcid Complete, we think they might fit your search criteria.Go to Trials
Image of Mayo Clinic in Rochester in Rochester, United States.

High Resolution Gastric Mapping and Gastroduodenal Manometry for Indigestion

18 - 80
All Sexes
Rochester, MN
Dyspepsia is a common problem attributed to gastric sensorimotor dysfunctions ie, delayed, or less frequently rapid gastric emptying (GE), impaired gastric accommodation, and increased gastric sensation. Therapeutic options manage symptoms, and there is no FDA approved medical therapy for dyspepsia. There is a need for better objective understanding of sensorimotor dysfunction in dyspepsia, as well as noninvasive, efficacious, safe, and inexpensive treatments for dyspepsia. The purpose of this research is to identify disturbances and characterize phenotypes in patients with functional dyspepsia, and to assess the correlations between symptoms (during the manometry and in daily life), gastric emptying, electrical activity (BSGM), and pressure activity (manometry).
Recruiting
Has No Placebo
Mayo Clinic in RochesterNicholas R Oblizajek, MD
Image of Hamilton Health Sciences in Hamilton, Canada.

Kiwifruit Extract for Constipation in Children

4 - 17
All Sexes
Hamilton, Canada
The goal of this pilot feasibility randomized controlled trial is to determine whether Actazin (kiwifruit extract) is a feasible and effective alternative to polyethylene glycol 3350 (PEG 3350) for maintenance therapy in children with functional constipation (FC). This study will include children aged 4 to 17 years who meet the Rome IV criteria for functional constipation. The main questions it aims to answer are: 1. Is it feasible to conduct a definitive, multi-centre trial comparing Actazin to PEG 3350 in children with FC? 2. What are the within-group differences in clinical outcomes such as stool frequency, abdominal pain, and laxative use over a 4-week period? Researchers will compare chewable Actazin tablets with placebo PEG 3350 powder to PEG 3350 powder with placebo Actazin tablets to see if Actazin is a viable non-pharmacologic natural health product alternative for treating FC. Participants will: Undergo an initial bowel cleanout using PEG 3350 and bisacodyl. Following, they will be randomized to one of two groups: 1. Actazin chewable tablets (titrate to effect: 600-2400 mg/day) + placebo PEG 3350 2. PEG 3350 (dose based on age and titratable to effect) + placebo Actazin chewable tablets Participants will take the assigned intervention daily for 4 weeks and complete a daily bowel diary recording stool frequency, consistency (Bristol Stool Scale), abdominal pain, and laxative use. They will have weekly follow-ups via phone or electronic survey to assess adherence, medication use, and adverse events. Additionally, a bi-weekly follow-up will be conducted for an additional 8 weeks to track longer-term outcomes. Outcomes: Primary feasibility outcomes include consent rate, adherence to allocated intervention, and 4-week follow-up completion rate. Secondary clinical outcomes include resolution of FC (Rome IV criteria), weekly stool frequency, abdominal pain episodes, use of rescue laxatives, and treatment palatability. This study is being conducted at McMaster Children's Hospital and is funded by the Hamilton Academic Health Sciences Organization (HAHSO). Data collection will be managed using the Lumedi™ platform, and safety will be overseen by a Data Safety Monitoring Board (DSMB).
Phase 2 & 3
Waitlist Available
Hamilton Health SciencesElyanne Ratcliffe, MD
Have you considered Pepcid Complete clinical trials? We made a collection of clinical trials featuring Pepcid Complete, we think they might fit your search criteria.Go to Trials
Image of Brigham and Women's Hospital in Boston, United States.

Low Thermal Plasma for Marginal Ulcers

18+
All Sexes
Boston, MA
The objective of the study is to investigate the treatment of marginal ulcers with Low Thermal plasma in an endoscopic setting. By a treatment of the ulcerated areas with argon plasma with low power settings (\~ 1 W) we hypothesize that the size of the ulcers will shrink, and the healing is accelerated compared to standard of care alone. Patients will benefit from this minimally invasive approach compared to a much more invasive surgical approach that comes with higher risks and hospital stay length time. From a societal and scientific perspective, this study aims to extend the well-documented clinical benefits of plasma technology - from external wound healing to internal ulcer treatment - within an endoscopic framework. The success of this study could pave the way for broader applications of LTP in the treatment of other endoscopically accessible conditions such as peptic ulcers, duodenal ulcers and esophageal ulcers. This advancement has the potential not only to improve patient outcomes through less invasive methods, but also to position LTP as a cornerstone in the future of gastroenterological wound management strategies.
Recruiting
Has No Placebo
Brigham and Women's HospitalChristopher C. Thompson, MD, MSc
Image of G. Oppenheimer Center for Neurobiology of Stress and Resilience in Los Angeles, United States.

Biofeedback for Functional Abdominal Bloating

18 - 80
All Sexes
Los Angeles, CA
Background. Abdominal distention is produced by an abnormal somatic postural tone. The authors developed an original biofeedback technique. In a randomized, placebo-controlled trial the authors demonstrated the superiority of biofeedback over placebo for the treatment of abdominal distention. However, the technique is technically complex and unpractical. Aim. To prove the efficacy of a noninstrumental biofeedback technique, transmitted by a standard training program, for the treatment of abdominal distension in different centers. Selection criteria. Episodes of visible abdominal distension. Intervention. Patients will be randomized into biofeedback and placebo groups. Three sessions of either biofeedback or placebo intervention will be performed during the first 3 weeks of the intervention period. Biofeedback: Patients will be taught to control abdominal and thoracic muscular activity by providing instructions using an original video support. In each center one operator will receive a standard training on how to deliver the noninstrumental biofeedback treatment. Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period. Placebo: Sham measurements of abdominal and thoracic motion will be performed, and a pill of placebo containing 0.21 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Recruiting
Paid Trial
G. Oppenheimer Center for Neurobiology of Stress and Resilience (+1 Sites)Fernando Azpiroz, MD
Have you considered Pepcid Complete clinical trials? We made a collection of clinical trials featuring Pepcid Complete, we think they might fit your search criteria.Go to Trials